Valid for Submission
D72.111 is a billable diagnosis code used to specify a medical diagnosis of lymphocytic variant hypereosinophilic syndrome [lhes]. The code D72.111 is valid during the fiscal year 2021 from October 01, 2020 through September 30, 2021 for the submission of HIPAA-covered transactions.
New 2021 ICD-10 Code
D72.111 is new to ICD-10 code set for the FY 2021, effective October 1, 2020. The National Center for Health Statistics (NCHS) has published an update to the ICD-10-CM diagnosis codes which became effective October 1, 2020. This is a new and revised code for the FY 2021 (October 1, 2020 - September 30, 2021).
Tabular List of Diseases and Injuries
The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with guidance for inclusions, exclusions, descriptions and more. The following references are applicable to the code D72.111:
Inclusion TermsInclusion Terms
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
- Lymphocyte variant hypereosinophilia
Code AlsoCode Also
A "code also" note instructs that two codes may be required to fully describe a condition, but this note does not provide sequencing direction.
- , if applicable, any associated lymphocytic neoplastic disorder
Index to Diseases and Injuries
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code D72.111 are found in the index:
Diagnostic Related Groups - MS-DRG Mapping
D72111 replaces the following previously assigned ICD-10 code(s):